Tu Z - Search Results

1

Chiral resolution of serial potent and selective σ₁ ligands and biological evaluation of (-)-[¹⁸F]TZ3108 in rodent and the nonhuman primate brain.

Yue X, Jin H, Luo Z, Liu H, Zhang X, McSpadden ED, Tian L, Flores HP, Perlmutter JS, Parsons SM, Tu Z. Yue X, et al. Among authors: tu z. Bioorg Med Chem. 2017 Feb 15;25(4):1533-1542. doi: 10.1016/j.bmc.2017.01.017. Epub 2017 Jan 16. Bioorg Med Chem. 2017. PMID: 28129990 Free PMC article.

2

Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).

Efange SM, von Hohenberg K, Khare AB, Tu Z, Mach RH, Parsons SM. Efange SM, et al. Among authors: tu z. Nucl Med Biol. 2000 Nov;27(8):749-55. doi: 10.1016/s0969-8051(00)00157-8. Nucl Med Biol. 2000. PMID: 11150707

3

Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.

Chu W, Tu Z, McElveen E, Xu J, Taylor M, Luedtke RR, Mach RH. Chu W, et al. Among authors: tu z. Bioorg Med Chem. 2005 Jan 3;13(1):77-87. doi: 10.1016/j.bmc.2004.09.054. Bioorg Med Chem. 2005. PMID: 15582454

4

Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer.

Tu Z, Dence CS, Ponde DE, Jones L, Wheeler KT, Welch MJ, Mach RH. Tu Z, et al. Nucl Med Biol. 2005 Jul;32(5):423-30. doi: 10.1016/j.nucmedbio.2005.03.008. Nucl Med Biol. 2005. PMID: 15982571

5

Synthesis and characterization of selective dopamine D2 receptor antagonists.

Vangveravong S, McElveen E, Taylor M, Xu J, Tu Z, Luedtke RR, Mach RH. Vangveravong S, et al. Among authors: tu z. Bioorg Med Chem. 2006 Feb 1;14(3):815-25. doi: 10.1016/j.bmc.2005.09.008. Epub 2005 Nov 8. Bioorg Med Chem. 2006. PMID: 16288878

6

N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.

Chu W, Zhang J, Zeng C, Rothfuss J, Tu Z, Chu Y, Reichert DE, Welch MJ, Mach RH. Chu W, et al. Among authors: tu z. J Med Chem. 2005 Dec 1;48(24):7637-47. doi: 10.1021/jm0506625. J Med Chem. 2005. PMID: 16302804

7

Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeled sigma2-receptor ligands.

Rowland DJ, Tu Z, Xu J, Ponde D, Mach RH, Welch MJ. Rowland DJ, et al. Among authors: tu z. J Nucl Med. 2006 Jun;47(6):1041-8. J Nucl Med. 2006. PMID: 16741315 Free article.

8

Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.

Tu Z, Xu J, Jones LA, Li S, Dumstorff C, Vangveravong S, Chen DL, Wheeler KT, Welch MJ, Mach RH. Tu Z, et al. J Med Chem. 2007 Jul 12;50(14):3194-204. doi: 10.1021/jm0614883. Epub 2007 Jun 19. J Med Chem. 2007. PMID: 17579383

9

Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.

Tu Z, Efange SM, Xu J, Li S, Jones LA, Parsons SM, Mach RH. Tu Z, et al. J Med Chem. 2009 Mar 12;52(5):1358-69. doi: 10.1021/jm8012344. J Med Chem. 2009. PMID: 19203271 Free PMC article.

10

[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.

Xu J, Chu W, Tu Z, Jones LA, Luedtke RR, Perlmutter JS, Mintun MA, Mach RH. Xu J, et al. Among authors: tu z. Synapse. 2009 Sep;63(9):717-28. doi: 10.1002/syn.20652. Synapse. 2009. PMID: 19425052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,422 results

Search Page

Filters